- Home
- Cardio-renal-metabolic UK Manchester Meeting 2024 sessions
Health inequalities in CVRM medicine
In this CVRM meeting session, Dr David Hargroves discussed health inequalities in CVRM, focusing on disparities in healthcare access, quality, outcomes, and patient experiences influenced by various factors. He emphasised the complexity of the issue and the need for tailored interventions, highlighting the NHS's Core20PLUS5 initiative and other resources designed to reduce these inequalities.
Lifestyle Medicine: A Multi-Disciplinary Multi-System Approach
In this CVRM meeting session, Dr Sundhya Raman emphasised the crucial role of lifestyle changes and a multi-disciplinary approach in managing CVRM conditions, highlighting dietary risks as a major driver of chronic diseases like CVD in the UK. She advocated for simpler dietary guidelines from the ESC, ACC and AHA, and presented studies demonstrating the positive impact of comprehensive lifestyle interventions on patient outcomes.
New approaches to patient education in diabetes
In this CVRM meeting session, Julie Brake stressed the crucial role of effective patient education in diabetes management, urging healthcare professionals to make every interaction count. Since most patients with diabetes manage their condition independently, it’s essential to equip them with the necessary knowledge, skills, and confidence. Julie Brake also identified several challenges and opportunities in scaling up diabetes education.
The intersection of CVRM and sleep disorders
In this CVRM meeting session, Dr Kevin Fernando highlighted the importance of sleep as a major cardiometabolic risk factor, focusing on its bidirectional relationship with conditions like obstructive sleep apnea/hypopnea syndrome (OSAHS). He stressed the need to integrate sleep counselling into routine cardiometabolic evaluations, citing research that both insufficient and excessive sleep increase the risk of type 2 diabetes and poor glycaemic control.
Implementing change in CVRM medicine
In this CVRM meeting session, Professor Kelvin Lee led a workshop showcasing a new accelerated early intervention program for heart attack patients which focused on optimising medication management, conducting comprehensive diabetes screening, and coordinating care. This approach significantly reduced hospitalisations and mortality rates and led to substantial cost savings. The initiative demonstrated huge success in improving patient outcomes and healthcare efficiency.
Looking at chronic kidney disease through diabetes tinted spectacles
In this CVRM meeting session, Professor Smeeta Sinha led a workshop highlighting the rising prevalence of CKD and its profound impact on both patient health and healthcare costs. Despite its significant implications, Professor Sinha believes CKD is currently under prioritised and warrants greater attention. She also provided insights into enhancing CKD diagnosis and treatment strategies.
Metabolic dysfunction associated steatotic liver disease (MASLD) – a threat to public health?
In this CVRM meeting session, Dr Kevin Fernando stressed the significance of acknowledging and tackling metabolic dysfunction-associated steatotic liver disease (MASLD), noting that it stems from metabolic issues rather than being solely a liver ailment. He also provided insights into tools and resources available to healthcare providers, along with lifestyle modification interventions, to address MASLD effectively.
Sex and Gender in CVRM Care: Proper care or Propaganda?
In this session of the CVRM meeting, Dr Sofia Ahmed emphasised the importance of incorporating sex and gender factors into CVRM science. She noted disparities in immune responses, cardiovascular risk, and medication adverse reactions between men and women. Dr Ahmed also discussed initiatives such as Canada's 2021 census and evolving clinical guidelines aimed at enhancing sex and gender inclusivity in research and healthcare practices.